Product |
CAS |
Molecular formula |
More |
(1-(1-(Furan-2-yl)ethyl)piperidin-3-yl)methanamine hydrochloride |
1420982-34-8 |
C12H21ClN2O |
More |
(1-(1-(Furan-2-yl)ethyl)piperidin-4-yl)methanamine hydrochloride |
1420789-56-5 |
C12H21ClN2O |
More |
1-(1-(Furan-2-yl)ethyl)-n-methylpiperidin-3-amine hydrochloride |
1420860-08-7 |
C12H21ClN2O |
More |
1-(1-(Furan-2-yl)ethyl)-n-methylpiperidin-4-amine hydrochloride |
1420982-53-1 |
C12H21ClN2O |
More |
1-(Furan-2-yl)-n-(pyrrolidin-2-ylmethyl)ethanamine hydrochloride |
1420789-65-6 |
C11H19ClN2O |
More |
1-(Furan-2-yl)-n-(pyrrolidin-3-ylmethyl)ethanamine hydrochloride |
1420862-19-6 |
C11H19ClN2O |
More |
1-(Furan-2-yl)-n-methyl-n-(pyrrolidin-2-ylmethyl)ethanamine hydrochlor |
1420860-15-6 |
C12H21ClN2O |
More |
1-(Furan-2-yl)-n-methyl-n-(pyrrolidin-3-ylmethyl)ethanamine hydrochlor |
1420862-25-4 |
C12H21ClN2O |
More |
1-(1-(Furan-2-yl)ethyl)pyrrolidin-3-amine hydrochloride |
1420826-75-0 |
C10H17ClN2O |
More |
(1-(1-(Furan-2-yl)ethyl)pyrrolidin-2-yl)methanamine hydrochloride |
1420826-95-4 |
C11H19ClN2O |
More |
(1-(1-(Furan-2-yl)ethyl)pyrrolidin-3-yl)methanamine hydrochloride |
1420862-34-5 |
C11H19ClN2O |
More |
1-(1-(Furan-2-yl)ethyl)piperazine hydrochloride |
1420810-79-2 |
C10H17ClN2O |
More |
1-(1-(Furan-2-yl)ethyl)-3-methylpiperazine hydrochloride |
1420861-54-6 |
C11H19ClN2O |
More |
1-(1-(Furan-2-yl)ethyl)-2-methylpiperazine hydrochloride |
1420839-73-1 |
C11H19ClN2O |
More |
1-(1-(Furan-2-yl)ethyl)piperazine-2-carboxylic acid hydrochloride |
1420786-32-8 |
C11H17ClN2O3 |
More |
1-(Furan-2-yl)-2-(piperidin-3-yloxy)ethanone hydrochloride |
1420795-33-0 |
C11H16ClNO3 |
More |
1-(Furan-2-yl)-2-(piperidin-4-yloxy)ethanone hydrochloride |
1420810-91-8 |
C11H16ClNO3 |
More |
1-(Furan-2-yl)-2-(piperidin-2-ylmethoxy)ethanone hydrochloride |
1420889-00-4 |
C12H18ClNO3 |
More |
1-(Furan-2-yl)-2-(piperidin-3-ylmethoxy)ethanone hydrochloride |
1420878-50-7 |
C12H18ClNO3 |
More |
1-(Furan-2-yl)-2-(piperidin-4-ylmethoxy)ethanone hydrochloride |
1420862-50-5 |
C12H18ClNO3 |
More |